ACAD News Acadia Pharmaceuticals Inc 39.26 $ACAD
Post# of 117
Posted On: 03/05/2015 10:53:31 PM
ACAD News Acadia Pharmaceuticals Inc 39.26 $ACAD
ExploreLearning Reflex Raises Test Scores for Struggling Students
GlobeNewswire - Wed Feb 18, 8:09AM CST
ExploreLearning, a member of Cambium Learning Group, Inc. (Nasdaq:ABCD), announced the findings of a new two-year research study showing that struggling students who used their award-winning math fact fluency program, Reflex, saw substantial gains on a widely used, nationally normed mathematics assessment.
ABCD: 2.84 (+0.10)
Kurzweil 1000 Version 14 Improves Learning Experience for Blind and Visually Impaired Users
GlobeNewswire - Tue Feb 03, 7:00AM CST
Kurzweil Education(TM), Inc., a division of Cambium Learning(R) Group, Inc. (Nasdaq:ABCD), today announced the availability of Kurzweil 1000(TM) Version 14, the latest version of its award-winning text-to-speech software that makes printed or electronic text readily available to people who are blind or visually impaired.
ABCD: 2.84 (+0.10)
Learning A-Z Launches New Referral Program
GlobeNewswire - Thu Jan 15, 7:00AM CST
Learning A-Z, an online provider of PreK-6 education solutions and part of Cambium Learning Group, Inc., announced today the launch of its newly formed referral program.
ABCD: 2.84 (+0.10)
Factors Driving Markets: New Outlook on Cambium Learning Group, Canterbury Park, Capella Education, Career Education and CareTrust
PR Newswire - Fri Dec 26, 7:10AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Cambium Learning Group (NASDAQ: ABCD), Canterbury Park (NASDAQ: CPHC), Capella Education (NASDAQ: CPLA), Career Education (NASDAQ: CECO), and CareTrust (NASDAQ: CTRE). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
CTRE: 12.93 (-0.48), CPHC: 10.07 (-0.43), CPLA: 65.60 (+0.20), ABCD: 2.84 (+0.10), CECO: 6.00 (unch)
Cambium Learning Group Earns Reader's Choice Top 100 Distinction
PR Newswire - Fri Dec 19, 10:43AM CST
Cambium Learning® Group, Inc. [NASDAQ: ABCD], the educational solutions and services company that leverages engaging, innovative technology to help all students reach their full potential, announced today that products innovated by two of its business units--ExploreLearning® and Voyager Sopris Learning(TM)-- were selected to be among District Administration magazine's 2014 Reader's Choice Top 100 Products.
ABCD: 2.84 (+0.10)
Learning A-Z Announces New Headsprout Educator Grant Program
PR Newswire - Mon Dec 15, 4:00AM CST
Learning A-Z(TM), a PreK-6 educational resource company and part of Cambium Learning® Group, Inc. (NASDAQ: ABCD), announced today the launch of the newly created Headsprout® Educator Grant Program.
ABCD: 2.84 (+0.10)
Cambium Learning Group Technology Solutions Earn 2014 Awards of Excellence from Tech & Learning Magazine
PR Newswire - Thu Dec 04, 4:00AM CST
Cambium Learning® Group, Inc. (NASDAQ: ABCD), the educational solutions and services company that leverages engaging, innovative technology to help all students reach their full potential, announced today that three of its business units -- ExploreLearning®, Kurzweil Education(TM), and Learning A-Z(TM) -- were among the winners of the 32nd Annual Tech & Learning Awards of Excellence for Best Upgraded Product.
ABCD: 2.84 (+0.10)
Kurzweil Education Announces Pilot Program for Kurzweil 3000-firefly in Jordanian Schools
PR Newswire Europe - Wed Nov 26, 2:22PM CST
Kurzweil Education(TM), a division of Cambium Learning((R)) Group, Inc. , announced today that Sensotec nv/sa, Kurzweil Education's development and localization partner based in Belgium, and the Jordan Education Initiative (JEI), one of Her Majesty Queen Rania Al-Abdullah's not-for-profit organizations in Amman, Jordan, have signed a Memorandum of Understanding to pilot Kurzweil 3000((R))-firefly((R)) in four schools.
ABCD: 2.84 (+0.10)
Cambium Learning Group: Valued Education In A Deep Value Stock
David Waldron - at Seeking Alpha - Wed Nov 19, 7:24AM CST
ABCD: 2.84 (+0.10)
Cambium Learning EPS of $0.02
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 5:19PM CST
ABCD: 2.84 (+0.10)
Cambium Learning Group Announces Third Quarter Earnings
PR Newswire - Thu Nov 06, 4:03PM CST
Cambium Learning® Group, Inc. (NASDAQ: ABCD, the "Company"
, a leading educational solutions and services company committed to helping all students reach their full potential by providing evidence-based solutions and expert professional services, announced today its financial results for the third quarter of 2014.
ABCD: 2.84 (+0.10)
Cambium Learning Group, Inc. Announces Date for 2014 Third-Quarter Earnings Release
PR Newswire - Wed Oct 29, 3:48PM CDT
Cambium Learning® Group, Inc. (NASDAQ: ABCD), (the "Company" , a leading educational solutions and services company committed to helping all students reach their full potential by providing evidence-based solutions and expert professional services, today announced that it will release its 2014 third-quarter financial results on Thursday, November 6, 2014. The release will be based on unaudited results through September 30, 2014.
ABCD: 2.84 (+0.10)
John Campbell of Cambium Learning Group has been selected by ExecRank as a Top Chief Executive Officer for 2014
PR Newswire - Mon Oct 13, 4:00AM CDT
Cambium Learning® Group, Inc. (NASDAQ: ABCD) is pleased to announce that John Campbell has been recognized by ExecRank as a Top Chief Executive Officer at a Micro-Cap Company for 2014. These rankings are based on statistical and algorithmic analysis of executive and company performance and are the result of more than three years of research and feedback from evaluation committees and top Chief Executives.
ABCD: 2.84 (+0.10)
Learning A-Z Launches ReadyTest A-Z
PR Newswire - Thu Oct 09, 4:00AM CDT
Learning A-Z(TM), a PreK-6 educational resource company and part of Cambium Learning® Group, Inc. (NASDAQ: ABCD), has launched a new website, ReadyTest A-Z.
ABCD: 2.84 (+0.10)
Cambium Learning Group Wins Six 2014 EDDIE Awards
PR Newswire - Fri Oct 03, 4:00AM CDT
Cambium Learning® Group, Inc. (NASDAQ: ABCD) announced today that it won six 2014 Education Software Review (EDDIE) Awards: two by ExploreLearning®, one by Kurzweil Education(TM), and three by Learning A-Z(TM).
ABCD: 2.84 (+0.10)
Voyager Sopris Learning's We Can Early Learning Curriculum Approved by Illinois Governor's Office of Early Childhood Development
PR Newswire - Wed Sep 17, 4:00AM CDT
Voyager Sopris Learning(TM) announced today that the State of Illinois Governor's Office of Early Childhood Development has recognized the We Can Early Learning Curriculum as an approved curriculum for PreK and Early Learning programs.
ABCD: 2.84 (+0.10)
Voyager Sopris Learning's Fall Webinar Series Brings Educators in Contact with World-Renowned Authors, Educators, and Researchers for Fifth Year
PR Newswire - Fri Sep 12, 4:00AM CDT
Voyager Sopris Learning(TM) announced today that its complimentary webinar series is open for registration. The fall 2014 webinars focus on ways to improve student outcomes--both academically and socially--and prepare students for college and career.
ABCD: 2.84 (+0.10)
Learning A-Z's Reading Solution Voted a Top Resource for Teachers and Students in Independent Survey
PR Newswire - Tue Sep 09, 4:00AM CDT
Learning A-Z, a PreK-6 educational resource company and business unit of Cambium Learning® Group, Inc. (NASDAQ: ABCD), announced today that its award-winning Reading Solution is the top-ranked online reading resource for teachers and students in an independent survey.
ABCD: 2.84 (+0.10)
Priceline Group Names New CEO for priceline.com Division - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 05, 11:40AM CST
Priceline Group Inc. (PCLN) recently announced the appointment of Paul J. Hennessy as the new chief executive officer (CEO) of its priceline.com division.
ABTL: 14.77 (+0.25), PETS: 15.11 (+0.03), EVLV: 6.25 (-0.11), PCLN: 1,231.90 (+6.23)
Tinder's New Premium Service to Cost More for Users Over 30 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 04, 2:14PM CST
IAC/InteractiveCorp (IACI) owned popular free mobile-dating app Tinder released its new premium service, Tinder Plus, in a bid to generate revenues.
ABTL: 14.77 (+0.25), PETS: 15.11 (+0.03), IACI: 69.36 (+0.90), TWTR: 47.35 (-0.22)
Alibaba Accused of Fake Orders to Pad Sales, Shares Bear the Brunt - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 04, 1:13PM CST
Alibaba's (BABA) journey as a public company hasn't exactly been a smooth one.
ABTL: 14.77 (+0.25), PETS: 15.11 (+0.03), JD: 29.00 (+1.28), BABA: 86.10 (+0.61)
Amazon.com (AMZN) Now Shows the 'Ship to Cuba' Option - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 03, 3:20PM CST
Amazon.com Inc (AMZN) seems to be laying the foundation to ship packages to Cuba.
AMZN: 387.83 (+5.11), ABTL: 14.77 (+0.25), PETS: 15.11 (+0.03), EVLV: 6.25 (-0.11)
Google's Android for Work: A Blessing for Enterprises? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 02, 4:20PM CST
In an attempt to dig into the business class pockets, Google Inc. (GOOGL) has finally rolled out Android for Work.
ABTL: 14.77 (+0.25), PETS: 15.11 (+0.03), GOOGL: 581.43 (+3.10), AAPL: 126.41 (-2.13)
Google Inc (GOOGL) Updates Flight Shopping Features - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 02, 3:20PM CST
Google Inc. (GOOGL) rolled out "Google Flights", the final version of its flight-shopping site, last week.
ABTL: 14.77 (+0.25), PETS: 15.11 (+0.03), EXPE: 91.38 (+1.51), GOOGL: 581.43 (+3.10)
Zacks Rank #1 Additions for Monday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 02, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday
CBRL: 151.16 (+1.59), AVA: 33.33 (+0.14), ABTL: 14.77 (+0.25), ESE: 39.60 (+0.55), BURL: 56.65 (-0.11)
Market Maker Surveillance Report. TTI, ABTL, AVEO, EYES, CLNE, XIN, Winning Stocks With Lowest Price Friction For Friday, February 27th 2015
M2 - Mon Mar 02, 5:29AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 5214 companies with "abnormal" market making, 2975 companies with positive Friction Factors and 3319 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Friday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. TETRA Technologies Inc (NYSE:TTI), Autobytel Inc (NASDAQ:ABTL), Aveo Pharmaceuticals Inc (NASDAQ:AVEO), VISION TWENTY-ONE INC (NASDAQ:EYES), Clean Energy Fuels Corp (NASDAQ:CLNE), iShares MSCI EAFE Index (CAD-Hedged) (NYSE:XIN). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
EYES: 17.07 (+2.16), ABTL: 14.77 (+0.25), XIN: 3.19 (-0.06), AVEO: 1.42 (-0.12), TTI: 5.52 (-0.03), CLNE: 5.54 (-0.09)
Nasdaq stocks posting largest percentage increases
AP - Fri Feb 27, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
XENT: 25.26 (+0.20), EGLE: 9.99 (+0.17), MNST: 140.03 (+0.49), AIRM: 52.87 (-0.60), UNXL: 6.47 (-0.01), FLML: 16.15 (+0.31), ABTL: 14.77 (+0.25), AKRX: 50.88 (-0.31), PGTI: 11.19 (-0.09), HEES: 24.97 (-0.18), TORM: 6.36 (-0.04), CNCE: 14.46 (-0.09), ROVI: 22.44 (+0.71)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Feb 27, 11:55AM CST
EYES: 17.07 (+2.16), UNXL: 6.47 (-0.01), AIRM: 52.87 (-0.60), DGI: 34.73 (-0.21), TBIO: 1.71 (-0.05), VTAE: 11.16 (+0.07), ENOC: 11.61 (+0.46), BIOC: 3.36 (-0.03), TTI: 5.52 (-0.03), CLNE: 5.54 (-0.09), CALI: 1.25 (+0.06), RESN: 11.05 (-0.39), EGL: 34.91 (-0.56), CYCC: 1.06 (-0.04), ABTL: 14.77 (+0.25), TUBE: 12.64 (-0.55), XIN: 3.19 (-0.06), CAS: 3.45 (+0.05), TCPI: 2.72 (-0.10), WTW: 9.55 (-0.42)
Autobytel +21.7% on big Q4 EPS beat, strong 2015 guidance
Seeking Alpha - at Seeking Alpha - Fri Feb 27, 11:31AM CST
ABTL: 14.77 (+0.25)
Google's Android is Finally Ready to go to Work! - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 27, 11:20AM CST
It has been almost eight months since Google first announced its concept of Android for Work at its Google I/O conference.
ABTL: 14.77 (+0.25), GOOGL: 581.43 (+3.10), EVLV: 6.25 (-0.11), AAPL: 126.41 (-2.13)
Amazon Hits New 52-Week High due to Strong Q4 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 27, 10:40AM CST
Shares of Amazon.com Inc. (AMZN) touched a new 52-week high of $389.4 on Feb 26, eventually closing at $384.8.
AMZN: 387.83 (+5.11), ABTL: 14.77 (+0.25), PETS: 15.11 (+0.03), EVLV: 6.25 (-0.11)
Autobytel (ABTL) CEO Jeff Coats on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 26, 10:00PM CST
ABTL: 14.77 (+0.25)
Autobytel posts 4Q profit
Automated Insights - Thu Feb 26, 7:07PM CST
IRVINE, Calif. (AP) _ Autobytel Inc. (ABTL) on Thursday reported fourth-quarter net income of $1.1 million.
ABTL: 14.77 (+0.25)
Priceline (PCLN) Prices EUR 1B Unsecured Senior Notes - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 26, 4:24PM CST
Priceline.com (PCLN) recently announced the pricing of Senior Unsecured Notes aggregating EUR1 billion, carrying a coupon rate of 1.8% due in 2027 in an underwritten public offering.
ABTL: 14.77 (+0.25), PETS: 15.11 (+0.03), EVLV: 6.25 (-0.11), PCLN: 1,231.90 (+6.23)
Autobytel beats by $0.20, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 26, 3:26PM CST
ABTL: 14.77 (+0.25)
Inaugural Books from Amazon Kindle Scout Next Week - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 25, 4:36PM CST
In October last year, Amazon.com Inc. (AMZN) introduced a crowd-sourced publishing platform, Kindle Scout, that allows readers to vote for those unpublished authors that they would like in their devices. The company is now ready to release the first batch of titles on Mar 3.
AMZN: 387.83 (+5.11), ABTL: 14.77 (+0.25), PETS: 15.11 (+0.03), EVLV: 6.25 (-0.11)
Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Feb 25, 4:35PM CST
HLF: 31.79 (+0.34), MNST: 140.03 (+0.49), NOG: 7.78 (-0.01), MAIN: 31.47 (+0.35), MVNR: 17.42 (+0.13), EVHC: 37.01 (-0.50), RP: 19.92 (+0.14), ENV: 56.02 (-0.41), BCEI: 27.04 (-0.52), CLNE: 5.54 (-0.09), MITT: 19.22 (+0.12), KBR: 15.81 (+0.03), NVAX: 8.94 (+0.11), PKT: 9.18 (+0.06), KND: 21.77 (-0.31), CSU: 25.36 (+0.08), OLED: 38.87 (+2.29), IM: 24.89 (+0.01), DGI: 34.73 (-0.21), AHT: 10.28 (-0.04), LYV: 26.21 (+0.06), ECOL: 51.59 (-0.16), PEGA: 20.04 (-0.29), PODD: 31.98 (+1.02), CROX: 11.45 (-0.07), AVD: 10.32 (-0.12), AL: 38.66 (+0.49), RBA: 25.25 (+0.01), ADSK: 62.95 (+0.43), ECPG: 39.81 (+0.65), AIRM: 52.87 (-0.60), ARUN: 24.41 (+0.01), ENOC: 11.61 (+0.46), AEGR: 28.32 (+0.30), MDRX: 12.26 (-0.06), RMTI: 10.41 (+0.01), HPTX: 29.80 (+0.07), PSIX: 57.79 (+0.79), ABTL: 14.77 (+0.25), PFMT: 4.25 (+0.10), R: 93.86 (+0.21), CERS: 4.45 (-0.01), EVC: 6.64 (+0.06), IMMR: 8.40 (+0.08), CUBE: 23.05 (+0.12), BLOX: 24.28 (+0.23), OUT: 30.36 (+0.09), OVTI: 27.08 (+0.01), MTZ: 21.43 (+0.45), APEI: 30.33 (-0.37), MENT: 23.22 (-0.10), BIO: 134.24 (+1.33), JCP: 7.72 (-0.16), PE: 14.25 (-0.24), NMBL: 25.65 (+0.16), GPS: 41.43 (-0.60), ROST: 104.95 (-0.17)
Glaucoma - Pipeline Review, H1 2015 - Featuring 50 Companies & 104 Drug Profiles
M2 - Tue Mar 03, 5:13AM CST
Research and Markets (http://www.researchandmarkets.com/research/8h3k7s/glaucoma) has announced the addition of the "Glaucoma - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Glaucoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Glaucoma and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - AC Immune SA - Acadia Pharmaceuticals Inc. - Aerie Pharmaceuticals, Inc. - Alcon, Inc. - Allergan, Inc. - Altacor Ltd. - Amakem NV - Asahi Kasei Pharma Corp. - AUS Bio Limited - Bausch & Lomb Incorporated - Bionure Farma, S.L. - Can-Fite BioPharma Ltd. - Cellular Biomedicine Group, Inc. - China Grand Wuhan General Pharmaceutical Research Institute - D. Western Therapeutics Institute, Inc. - DNAVEC Corporation - Dompe Farmaceutici S.p.A. - F. Hoffmann-La Roche Ltd. - Foamix Pharmaceuticals Ltd. - Gene Signal International SA - Gilead Sciences, Inc. - Handok Inc. - High Point Pharmaceuticals, LLC - Icon Bioscience, Inc. - IMMD Inc. - Inotek Pharmaceuticals Corporation - InSite Vision Incorporated - Lacer, S.A. - Merck & Co., Inc. - Merz Pharma GmbH & Co. KgaA For more information visit http://www.researchandmarkets.com/research/8h3k7s/glaucoma
CANF: 4.47 (+0.07), AGN: 235.41 (-0.27), ACAD: 39.26 (+1.12), ITEK: 6.00 (unch), GILD: 103.42 (+0.36), MRK: 57.98 (+0.10), FOMX: 9.25 (+0.28), AERI: 28.92 (+0.12), CBMG: 32.39 (+2.89)
Investors Are Best To Avoid The IShares Nasdaq Biotechnology ETF
Investing Healthcare - at Seeking Alpha - Mon Mar 02, 9:24AM CST
JNJ: 102.52 (+0.87), BIIB: 425.61 (+11.48), ACAD: 39.26 (+1.12), SPY: 210.46 (+0.23), PCYC: 254.22 (+23.74), GILD: 103.42 (+0.36), MRK: 57.98 (+0.10), ALXN: 185.79 (+3.26), IBB: 347.67 (+7.58), CELG: 120.71 (+1.14)
Steel Is At 5-Year Lows - Cramer's Lightning Round (2/27/15)
SA Editor Mohit Manghnani - at Seeking Alpha - Mon Mar 02, 4:31AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Friday, February 27. Bullish Calls: Acadia Pharmaceuticals (NASDAQ: ACAD ): "We did a piece on Parkinson's and I think they may have something. I like this...
NBL: 46.07 (-1.14), CXO: 113.46 (-0.70), RDS.B: 65.62 (-0.35), ACAD: 39.26 (+1.12), RDS.A: 62.34 (-0.58), TLM: 7.74 (unch), NUE: 47.64 (+0.23), ARUN: 24.41 (+0.01), WOR: 26.51 (-0.16), PGH: 3.16 (-0.10), NXPI: 98.67 (-0.80), ALK: 64.64 (-1.13), ALGT: 189.73 (+4.93)
'Mad Money' Lightning Round: Allegiant Travel Good, Spirit Airlines Better
at The Street - Sat Feb 28, 5:00AM CST
Cramer said Acadia Pharmaceuticals is good but speculative and he's ringing the register on Aruba Networks.
NBL: 46.07 (-1.14), CXO: 113.46 (-0.70), ACAD: 39.26 (+1.12), SAVE: 76.32 (-0.06), TLM: 7.74 (unch), NUE: 47.64 (+0.23), ARUN: 24.41 (+0.01), WOR: 26.51 (-0.16), PGH: 3.16 (-0.10), NXPI: 98.67 (-0.80), ALK: 64.64 (-1.13), ALGT: 189.73 (+4.93)
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Feb 27, 7:31PM CST
What doesn't kill this market makes it stronger, Cramer says. His game plan includes Netflix, Berkshire Hathaway and Costco, among others.
CXO: 113.46 (-0.70), NBL: 46.07 (-1.14), MNST: 140.03 (+0.49), TLM: 7.74 (unch), HON: 103.13 (+0.08), ARUN: 24.41 (+0.01), XOM: 86.74 (-0.44), WOR: 26.51 (-0.16), BBY: 39.63 (-0.16), ATEN: 4.44 (+0.13), ACAD: 39.26 (+1.12), SAVE: 76.32 (-0.06), TGT: 78.20 (+0.48), COST: 151.17 (+4.00), HAWK: 35.14 (-0.42), PGH: 3.16 (-0.10), KR: 74.31 (+4.66), NUE: 47.64 (+0.23), NXPI: 98.67 (-0.80), ALK: 64.64 (-1.13), PLKI: 61.12 (+0.26), ALGT: 189.73 (+4.93), WWAV: 42.42 (-0.06), NFLX: 467.65 (-2.12), PCTY: 28.44 (-0.24), AZO: 650.97 (-1.51), BRK.B: 146.06 (+1.14)
Acadia Pharmaceuticals: Strong Balance Sheet And Several Near-Term Catalysts
Kanak Kanti De - at Seeking Alpha - Fri Feb 27, 3:02PM CST
ACAD: 39.26 (+1.12)
ACADIA Pharmaceuticals' (ACAD) CEO Uli Hacksell on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 26, 8:24PM CST
ACAD: 39.26 (+1.12)
Acadia reports 4Q loss
Automated Insights - Thu Feb 26, 6:22PM CST
SAN DIEGO (AP) _ Acadia Pharmaceuticals Inc. (ACAD) on Thursday reported a loss of $28.4 million in its fourth quarter.
ACAD: 39.26 (+1.12)
ACADIA Pharma misses by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 26, 3:39PM CST
ACAD: 39.26 (+1.12)
Will Epizyme (EPZM) Miss Estimates This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 25, 10:00AM CST
Epizyme, Inc. (EPZM) is expected to report its fourth-quarter 2014 results on Feb 26 and carries a Zacks Rank #3 with an Earnings ESP of 0.00%.
ACAD: 39.26 (+1.12), AMRN: 1.67 (-0.02), EPZM: 24.41 (+0.40)
Is a Surprise Coming for ACADIA Pharmaceuticals (ACAD) This Earnings Season? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 25, 7:54AM CST
ACADIA Pharmaceuticals is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
ACAD: 39.26 (+1.12)
Merrimack Pharmaceuticals (MACK): A Miss this Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 24, 3:10PM CST
Merrimack Pharmaceuticals, Inc. (MACK) is slated to report its fourth-quarter 2014 results on Feb 26 and carries a Zacks Rank #3 with an Earnings ESP of 0.00%.
MACK: 12.48 (+0.70), ACAD: 39.26 (+1.12), BAX: 69.21 (-0.04), AMRN: 1.67 (-0.02)
Will Aegerion (AEGR) Miss Earnings Estimates This Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 24, 2:40PM CST
Aegerion Pharmaceuticals, Inc. (AEGR), slated to report its fourth-quarter 2014 results on Feb 26, carries a Zacks Rank #3 (Hold) with an Earnings ESP of -220.00%.
ACAD: 39.26 (+1.12), AMRN: 1.67 (-0.02), SRPT: 14.08 (+0.02), AEGR: 28.32 (+0.30)
Will Allscripts (MDRX) Surprise Earnings Estimates in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 24, 11:20AM CST
Allscripts Healthcare Solutions Inc (MDRX) is set to report fourth-quarter fiscal 2014 results on Feb 26.
IPXL: 40.08 (-0.32), ACAD: 39.26 (+1.12), MDRX: 12.26 (-0.06), HPTX: 29.80 (+0.07)
Will DexCom (DXCM) Loss Better Estimates this Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 23, 11:10AM CST
We expect DexCom Inc. (DXCM) to post a narrower-than-expected loss figure when it reports fourth quarter and full year 2014 results on Feb 25.
IPXL: 40.08 (-0.32), ACAD: 39.26 (+1.12), DXCM: 60.55 (+0.67), HPTX: 29.80 (+0.07)
Will Wright Medical (WMGI) Disappoint Earnings Again in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 23, 11:00AM CST
Wright Medical Group Inc. (WMGI) is set to report fourth-quarter 2014 results on Feb 25.
IPXL: 40.08 (-0.32), ACAD: 39.26 (+1.12), WMGI: 26.32 (+0.94), HPTX: 29.80 (+0.07)
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q4 2014 Update
John Vincent - at Seeking Alpha - Sat Feb 21, 3:37PM CST
MDLZ: 36.51 (+0.07), DAL: 44.39 (-0.76), KSU: 116.03 (-0.11), AMP: 134.41 (+0.79), LM: 57.25 (+0.25), PCP: 216.34 (+2.82), GOOG: 575.33 (+1.96), HLT: 29.03 (+0.07), DLTR: 79.43 (+0.59), LYB: 87.98 (+0.74), COF: 78.89 (+0.24), FOXA: 34.87 (-0.10), CAR: 60.63 (-0.06), ABBV: 56.86 (-3.41), LOW: 74.56 (+0.54), MA: 92.81 (+1.10), MU: 29.28 (+0.02), ETN: 69.35 (-0.30), FB: 81.21 (+0.32), POT: 34.42 (-1.04), LNG: 78.41 (-0.02), IR: 67.68 (+0.68), NXPI: 98.67 (-0.80), MGM: 21.93 (-0.15), HIG: 40.99 (+0.29), QUNR: 28.99 (+0.39), NFX: 32.77 (-0.41), PXD: 160.44 (-2.57), ABEV: 6.14 (-0.02), ALXN: 185.79 (+3.26), CCI: 86.26 (+0.44), ACT: 295.70 (-0.44), LBTYK: 52.88 (+0.05), C: 53.56 (-0.11), ILMN: 200.13 (+7.45), AON: 100.23 (+0.60), CCE: 44.39 (-0.46), HUM: 162.11 (+1.89), AGN: 235.41 (-0.27), ANTM: 146.85 (+0.30), ACAD: 39.26 (+1.12), LBTYA: 55.00 (+0.14), ALLE: 58.11 (-0.34), GOOGL: 581.43 (+3.10), CTRP: 46.23 (+0.39), BK: 39.19 (-0.25), APD: 154.86 (+0.12), GLNG: 34.35 (+4.84), BRCM: 44.90 (-0.30), BAC: 16.00 (+0.16), NFLX: 467.65 (-2.12), CI: 122.51 (+0.65), HCA: 72.91 (-2.02), BIDU: 214.23 (+6.54), DVA: 76.93 (+0.18), LRCX: 80.77 (-0.10), MHK: 185.18 (+0.15), CP: 193.88 (+3.09), BABA: 86.10 (+0.61)
Can Greatbatch (GB) Keep the Earnings Streak Alive in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 20, 10:20AM CST
We expect Greatbatch Inc. (GB) to beat earnings when the company reports its fourth quarter and full year 2014 financial numbers on Feb 24.
IPXL: 40.08 (-0.32), ACAD: 39.26 (+1.12), GB: 54.73 (+0.34), HPTX: 29.80 (+0.07)
Ecolab's (ECL) Q4 Earnings: Will it Disappoint Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 20, 10:10AM CST
Our proven model does not conclusively show that Ecolab Inc. (ECL) is likely to beat earnings this quarter.
BLUE: 112.23 (+12.18), ENDP: 87.71 (+2.06), ACAD: 39.26 (+1.12), ECL: 116.77 (+0.59)
Next Week In Biotech: Arena And Vivus Report, Radiesse And Avedro Ad Comms
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 20, 8:00AM CST
Every Friday morning, Seeking Alpha posts a calendar of the next week's expected biotech events to start a forward-looking conversation. Please be aware that dates and events can be subject to change. Please let us know in a comment or message if you...
LXRX: 1.12 (+0.07), AMRN: 1.67 (-0.02), HWAY: 22.15 (-0.13), HLS: 42.28 (-0.44), CYBX: 72.03 (+0.84), ESRX: 84.28 (-0.55), ECYT: 6.25 (-0.48), DXCM: 60.55 (+0.67), NSTG: 12.00 (-0.28), SRPT: 14.08 (+0.02), HZNP: 20.84 (-0.33), MDXG: 10.33 (+0.31), DEPO: 24.21 (+0.56), ANIK: 39.96 (+0.50), NKTR: 13.30 (-0.09), KERX: 13.19 (-0.07), ALIM: 4.90 (-0.31), EPZM: 24.41 (+0.40), AEGR: 28.32 (+0.30), MDRX: 12.26 (-0.06), ELGX: 15.96 (-0.08), NUVA: 45.23 (+0.22), HPTX: 29.80 (+0.07), GNMK: 12.82 (+0.24), MDVN: 127.08 (+6.07), HBIO: 5.51 (-0.10), ACAD: 39.26 (+1.12), ST: 56.98 (+0.95), RPTP: 10.77 (+0.47), FMI: 46.97 (-0.32), GMED: 23.76 (-0.27), JAZZ: 174.76 (+2.02), PTCT: 72.72 (+2.26), INFI: 16.51 (+0.34), ARNA: 4.23 (-0.09), EXEL: 3.11 (+0.06), NEO: 4.96 (+0.24), EXAS: 22.43 (+0.53), ALKS: 71.22 (+0.42), HTWR: 85.89 (+1.21), MNKD: 5.73 (-0.21), IPXL: 40.08 (-0.32), SQNM: 3.62 (-0.03), HALO: 15.39 (-0.31), ISIS: 71.76 (+1.60), CLVS: 79.66 (+2.26), BIO: 134.24 (+1.33), BIOS: 5.20 (-0.01), PCRX: 98.40 (+3.01)
ExploreLearning Reflex Raises Test Scores for Struggling Students
GlobeNewswire - Wed Feb 18, 8:09AM CST
ExploreLearning, a member of Cambium Learning Group, Inc. (Nasdaq:ABCD), announced the findings of a new two-year research study showing that struggling students who used their award-winning math fact fluency program, Reflex, saw substantial gains on a widely used, nationally normed mathematics assessment.
ABCD: 2.84 (+0.10)
Kurzweil 1000 Version 14 Improves Learning Experience for Blind and Visually Impaired Users
GlobeNewswire - Tue Feb 03, 7:00AM CST
Kurzweil Education(TM), Inc., a division of Cambium Learning(R) Group, Inc. (Nasdaq:ABCD), today announced the availability of Kurzweil 1000(TM) Version 14, the latest version of its award-winning text-to-speech software that makes printed or electronic text readily available to people who are blind or visually impaired.
ABCD: 2.84 (+0.10)
Learning A-Z Launches New Referral Program
GlobeNewswire - Thu Jan 15, 7:00AM CST
Learning A-Z, an online provider of PreK-6 education solutions and part of Cambium Learning Group, Inc., announced today the launch of its newly formed referral program.
ABCD: 2.84 (+0.10)
Factors Driving Markets: New Outlook on Cambium Learning Group, Canterbury Park, Capella Education, Career Education and CareTrust
PR Newswire - Fri Dec 26, 7:10AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Cambium Learning Group (NASDAQ: ABCD), Canterbury Park (NASDAQ: CPHC), Capella Education (NASDAQ: CPLA), Career Education (NASDAQ: CECO), and CareTrust (NASDAQ: CTRE). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
CTRE: 12.93 (-0.48), CPHC: 10.07 (-0.43), CPLA: 65.60 (+0.20), ABCD: 2.84 (+0.10), CECO: 6.00 (unch)
Cambium Learning Group Earns Reader's Choice Top 100 Distinction
PR Newswire - Fri Dec 19, 10:43AM CST
Cambium Learning® Group, Inc. [NASDAQ: ABCD], the educational solutions and services company that leverages engaging, innovative technology to help all students reach their full potential, announced today that products innovated by two of its business units--ExploreLearning® and Voyager Sopris Learning(TM)-- were selected to be among District Administration magazine's 2014 Reader's Choice Top 100 Products.
ABCD: 2.84 (+0.10)
Learning A-Z Announces New Headsprout Educator Grant Program
PR Newswire - Mon Dec 15, 4:00AM CST
Learning A-Z(TM), a PreK-6 educational resource company and part of Cambium Learning® Group, Inc. (NASDAQ: ABCD), announced today the launch of the newly created Headsprout® Educator Grant Program.
ABCD: 2.84 (+0.10)
Cambium Learning Group Technology Solutions Earn 2014 Awards of Excellence from Tech & Learning Magazine
PR Newswire - Thu Dec 04, 4:00AM CST
Cambium Learning® Group, Inc. (NASDAQ: ABCD), the educational solutions and services company that leverages engaging, innovative technology to help all students reach their full potential, announced today that three of its business units -- ExploreLearning®, Kurzweil Education(TM), and Learning A-Z(TM) -- were among the winners of the 32nd Annual Tech & Learning Awards of Excellence for Best Upgraded Product.
ABCD: 2.84 (+0.10)
Kurzweil Education Announces Pilot Program for Kurzweil 3000-firefly in Jordanian Schools
PR Newswire Europe - Wed Nov 26, 2:22PM CST
Kurzweil Education(TM), a division of Cambium Learning((R)) Group, Inc. , announced today that Sensotec nv/sa, Kurzweil Education's development and localization partner based in Belgium, and the Jordan Education Initiative (JEI), one of Her Majesty Queen Rania Al-Abdullah's not-for-profit organizations in Amman, Jordan, have signed a Memorandum of Understanding to pilot Kurzweil 3000((R))-firefly((R)) in four schools.
ABCD: 2.84 (+0.10)
Cambium Learning Group: Valued Education In A Deep Value Stock
David Waldron - at Seeking Alpha - Wed Nov 19, 7:24AM CST
ABCD: 2.84 (+0.10)
Cambium Learning EPS of $0.02
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 5:19PM CST
ABCD: 2.84 (+0.10)
Cambium Learning Group Announces Third Quarter Earnings
PR Newswire - Thu Nov 06, 4:03PM CST
Cambium Learning® Group, Inc. (NASDAQ: ABCD, the "Company"
, a leading educational solutions and services company committed to helping all students reach their full potential by providing evidence-based solutions and expert professional services, announced today its financial results for the third quarter of 2014. ABCD: 2.84 (+0.10)
Cambium Learning Group, Inc. Announces Date for 2014 Third-Quarter Earnings Release
PR Newswire - Wed Oct 29, 3:48PM CDT
Cambium Learning® Group, Inc. (NASDAQ: ABCD), (the "Company"
, a leading educational solutions and services company committed to helping all students reach their full potential by providing evidence-based solutions and expert professional services, today announced that it will release its 2014 third-quarter financial results on Thursday, November 6, 2014. The release will be based on unaudited results through September 30, 2014. ABCD: 2.84 (+0.10)
John Campbell of Cambium Learning Group has been selected by ExecRank as a Top Chief Executive Officer for 2014
PR Newswire - Mon Oct 13, 4:00AM CDT
Cambium Learning® Group, Inc. (NASDAQ: ABCD) is pleased to announce that John Campbell has been recognized by ExecRank as a Top Chief Executive Officer at a Micro-Cap Company for 2014. These rankings are based on statistical and algorithmic analysis of executive and company performance and are the result of more than three years of research and feedback from evaluation committees and top Chief Executives.
ABCD: 2.84 (+0.10)
Learning A-Z Launches ReadyTest A-Z
PR Newswire - Thu Oct 09, 4:00AM CDT
Learning A-Z(TM), a PreK-6 educational resource company and part of Cambium Learning® Group, Inc. (NASDAQ: ABCD), has launched a new website, ReadyTest A-Z.
ABCD: 2.84 (+0.10)
Cambium Learning Group Wins Six 2014 EDDIE Awards
PR Newswire - Fri Oct 03, 4:00AM CDT
Cambium Learning® Group, Inc. (NASDAQ: ABCD) announced today that it won six 2014 Education Software Review (EDDIE) Awards: two by ExploreLearning®, one by Kurzweil Education(TM), and three by Learning A-Z(TM).
ABCD: 2.84 (+0.10)
Voyager Sopris Learning's We Can Early Learning Curriculum Approved by Illinois Governor's Office of Early Childhood Development
PR Newswire - Wed Sep 17, 4:00AM CDT
Voyager Sopris Learning(TM) announced today that the State of Illinois Governor's Office of Early Childhood Development has recognized the We Can Early Learning Curriculum as an approved curriculum for PreK and Early Learning programs.
ABCD: 2.84 (+0.10)
Voyager Sopris Learning's Fall Webinar Series Brings Educators in Contact with World-Renowned Authors, Educators, and Researchers for Fifth Year
PR Newswire - Fri Sep 12, 4:00AM CDT
Voyager Sopris Learning(TM) announced today that its complimentary webinar series is open for registration. The fall 2014 webinars focus on ways to improve student outcomes--both academically and socially--and prepare students for college and career.
ABCD: 2.84 (+0.10)
Learning A-Z's Reading Solution Voted a Top Resource for Teachers and Students in Independent Survey
PR Newswire - Tue Sep 09, 4:00AM CDT
Learning A-Z, a PreK-6 educational resource company and business unit of Cambium Learning® Group, Inc. (NASDAQ: ABCD), announced today that its award-winning Reading Solution is the top-ranked online reading resource for teachers and students in an independent survey.
ABCD: 2.84 (+0.10)
Priceline Group Names New CEO for priceline.com Division - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 05, 11:40AM CST
Priceline Group Inc. (PCLN) recently announced the appointment of Paul J. Hennessy as the new chief executive officer (CEO) of its priceline.com division.
ABTL: 14.77 (+0.25), PETS: 15.11 (+0.03), EVLV: 6.25 (-0.11), PCLN: 1,231.90 (+6.23)
Tinder's New Premium Service to Cost More for Users Over 30 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 04, 2:14PM CST
IAC/InteractiveCorp (IACI) owned popular free mobile-dating app Tinder released its new premium service, Tinder Plus, in a bid to generate revenues.
ABTL: 14.77 (+0.25), PETS: 15.11 (+0.03), IACI: 69.36 (+0.90), TWTR: 47.35 (-0.22)
Alibaba Accused of Fake Orders to Pad Sales, Shares Bear the Brunt - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 04, 1:13PM CST
Alibaba's (BABA) journey as a public company hasn't exactly been a smooth one.
ABTL: 14.77 (+0.25), PETS: 15.11 (+0.03), JD: 29.00 (+1.28), BABA: 86.10 (+0.61)
Amazon.com (AMZN) Now Shows the 'Ship to Cuba' Option - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 03, 3:20PM CST
Amazon.com Inc (AMZN) seems to be laying the foundation to ship packages to Cuba.
AMZN: 387.83 (+5.11), ABTL: 14.77 (+0.25), PETS: 15.11 (+0.03), EVLV: 6.25 (-0.11)
Google's Android for Work: A Blessing for Enterprises? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 02, 4:20PM CST
In an attempt to dig into the business class pockets, Google Inc. (GOOGL) has finally rolled out Android for Work.
ABTL: 14.77 (+0.25), PETS: 15.11 (+0.03), GOOGL: 581.43 (+3.10), AAPL: 126.41 (-2.13)
Google Inc (GOOGL) Updates Flight Shopping Features - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 02, 3:20PM CST
Google Inc. (GOOGL) rolled out "Google Flights", the final version of its flight-shopping site, last week.
ABTL: 14.77 (+0.25), PETS: 15.11 (+0.03), EXPE: 91.38 (+1.51), GOOGL: 581.43 (+3.10)
Zacks Rank #1 Additions for Monday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 02, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday
CBRL: 151.16 (+1.59), AVA: 33.33 (+0.14), ABTL: 14.77 (+0.25), ESE: 39.60 (+0.55), BURL: 56.65 (-0.11)
Market Maker Surveillance Report. TTI, ABTL, AVEO, EYES, CLNE, XIN, Winning Stocks With Lowest Price Friction For Friday, February 27th 2015
M2 - Mon Mar 02, 5:29AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 5214 companies with "abnormal" market making, 2975 companies with positive Friction Factors and 3319 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Friday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. TETRA Technologies Inc (NYSE:TTI), Autobytel Inc (NASDAQ:ABTL), Aveo Pharmaceuticals Inc (NASDAQ:AVEO), VISION TWENTY-ONE INC (NASDAQ:EYES), Clean Energy Fuels Corp (NASDAQ:CLNE), iShares MSCI EAFE Index (CAD-Hedged) (NYSE:XIN). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
EYES: 17.07 (+2.16), ABTL: 14.77 (+0.25), XIN: 3.19 (-0.06), AVEO: 1.42 (-0.12), TTI: 5.52 (-0.03), CLNE: 5.54 (-0.09)
Nasdaq stocks posting largest percentage increases
AP - Fri Feb 27, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
XENT: 25.26 (+0.20), EGLE: 9.99 (+0.17), MNST: 140.03 (+0.49), AIRM: 52.87 (-0.60), UNXL: 6.47 (-0.01), FLML: 16.15 (+0.31), ABTL: 14.77 (+0.25), AKRX: 50.88 (-0.31), PGTI: 11.19 (-0.09), HEES: 24.97 (-0.18), TORM: 6.36 (-0.04), CNCE: 14.46 (-0.09), ROVI: 22.44 (+0.71)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Feb 27, 11:55AM CST
EYES: 17.07 (+2.16), UNXL: 6.47 (-0.01), AIRM: 52.87 (-0.60), DGI: 34.73 (-0.21), TBIO: 1.71 (-0.05), VTAE: 11.16 (+0.07), ENOC: 11.61 (+0.46), BIOC: 3.36 (-0.03), TTI: 5.52 (-0.03), CLNE: 5.54 (-0.09), CALI: 1.25 (+0.06), RESN: 11.05 (-0.39), EGL: 34.91 (-0.56), CYCC: 1.06 (-0.04), ABTL: 14.77 (+0.25), TUBE: 12.64 (-0.55), XIN: 3.19 (-0.06), CAS: 3.45 (+0.05), TCPI: 2.72 (-0.10), WTW: 9.55 (-0.42)
Autobytel +21.7% on big Q4 EPS beat, strong 2015 guidance
Seeking Alpha - at Seeking Alpha - Fri Feb 27, 11:31AM CST
ABTL: 14.77 (+0.25)
Google's Android is Finally Ready to go to Work! - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 27, 11:20AM CST
It has been almost eight months since Google first announced its concept of Android for Work at its Google I/O conference.
ABTL: 14.77 (+0.25), GOOGL: 581.43 (+3.10), EVLV: 6.25 (-0.11), AAPL: 126.41 (-2.13)
Amazon Hits New 52-Week High due to Strong Q4 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 27, 10:40AM CST
Shares of Amazon.com Inc. (AMZN) touched a new 52-week high of $389.4 on Feb 26, eventually closing at $384.8.
AMZN: 387.83 (+5.11), ABTL: 14.77 (+0.25), PETS: 15.11 (+0.03), EVLV: 6.25 (-0.11)
Autobytel (ABTL) CEO Jeff Coats on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 26, 10:00PM CST
ABTL: 14.77 (+0.25)
Autobytel posts 4Q profit
Automated Insights - Thu Feb 26, 7:07PM CST
IRVINE, Calif. (AP) _ Autobytel Inc. (ABTL) on Thursday reported fourth-quarter net income of $1.1 million.
ABTL: 14.77 (+0.25)
Priceline (PCLN) Prices EUR 1B Unsecured Senior Notes - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 26, 4:24PM CST
Priceline.com (PCLN) recently announced the pricing of Senior Unsecured Notes aggregating EUR1 billion, carrying a coupon rate of 1.8% due in 2027 in an underwritten public offering.
ABTL: 14.77 (+0.25), PETS: 15.11 (+0.03), EVLV: 6.25 (-0.11), PCLN: 1,231.90 (+6.23)
Autobytel beats by $0.20, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 26, 3:26PM CST
ABTL: 14.77 (+0.25)
Inaugural Books from Amazon Kindle Scout Next Week - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 25, 4:36PM CST
In October last year, Amazon.com Inc. (AMZN) introduced a crowd-sourced publishing platform, Kindle Scout, that allows readers to vote for those unpublished authors that they would like in their devices. The company is now ready to release the first batch of titles on Mar 3.
AMZN: 387.83 (+5.11), ABTL: 14.77 (+0.25), PETS: 15.11 (+0.03), EVLV: 6.25 (-0.11)
Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Feb 25, 4:35PM CST
HLF: 31.79 (+0.34), MNST: 140.03 (+0.49), NOG: 7.78 (-0.01), MAIN: 31.47 (+0.35), MVNR: 17.42 (+0.13), EVHC: 37.01 (-0.50), RP: 19.92 (+0.14), ENV: 56.02 (-0.41), BCEI: 27.04 (-0.52), CLNE: 5.54 (-0.09), MITT: 19.22 (+0.12), KBR: 15.81 (+0.03), NVAX: 8.94 (+0.11), PKT: 9.18 (+0.06), KND: 21.77 (-0.31), CSU: 25.36 (+0.08), OLED: 38.87 (+2.29), IM: 24.89 (+0.01), DGI: 34.73 (-0.21), AHT: 10.28 (-0.04), LYV: 26.21 (+0.06), ECOL: 51.59 (-0.16), PEGA: 20.04 (-0.29), PODD: 31.98 (+1.02), CROX: 11.45 (-0.07), AVD: 10.32 (-0.12), AL: 38.66 (+0.49), RBA: 25.25 (+0.01), ADSK: 62.95 (+0.43), ECPG: 39.81 (+0.65), AIRM: 52.87 (-0.60), ARUN: 24.41 (+0.01), ENOC: 11.61 (+0.46), AEGR: 28.32 (+0.30), MDRX: 12.26 (-0.06), RMTI: 10.41 (+0.01), HPTX: 29.80 (+0.07), PSIX: 57.79 (+0.79), ABTL: 14.77 (+0.25), PFMT: 4.25 (+0.10), R: 93.86 (+0.21), CERS: 4.45 (-0.01), EVC: 6.64 (+0.06), IMMR: 8.40 (+0.08), CUBE: 23.05 (+0.12), BLOX: 24.28 (+0.23), OUT: 30.36 (+0.09), OVTI: 27.08 (+0.01), MTZ: 21.43 (+0.45), APEI: 30.33 (-0.37), MENT: 23.22 (-0.10), BIO: 134.24 (+1.33), JCP: 7.72 (-0.16), PE: 14.25 (-0.24), NMBL: 25.65 (+0.16), GPS: 41.43 (-0.60), ROST: 104.95 (-0.17)
Glaucoma - Pipeline Review, H1 2015 - Featuring 50 Companies & 104 Drug Profiles
M2 - Tue Mar 03, 5:13AM CST
Research and Markets (http://www.researchandmarkets.com/research/8h3k7s/glaucoma) has announced the addition of the "Glaucoma - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Glaucoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Glaucoma and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - AC Immune SA - Acadia Pharmaceuticals Inc. - Aerie Pharmaceuticals, Inc. - Alcon, Inc. - Allergan, Inc. - Altacor Ltd. - Amakem NV - Asahi Kasei Pharma Corp. - AUS Bio Limited - Bausch & Lomb Incorporated - Bionure Farma, S.L. - Can-Fite BioPharma Ltd. - Cellular Biomedicine Group, Inc. - China Grand Wuhan General Pharmaceutical Research Institute - D. Western Therapeutics Institute, Inc. - DNAVEC Corporation - Dompe Farmaceutici S.p.A. - F. Hoffmann-La Roche Ltd. - Foamix Pharmaceuticals Ltd. - Gene Signal International SA - Gilead Sciences, Inc. - Handok Inc. - High Point Pharmaceuticals, LLC - Icon Bioscience, Inc. - IMMD Inc. - Inotek Pharmaceuticals Corporation - InSite Vision Incorporated - Lacer, S.A. - Merck & Co., Inc. - Merz Pharma GmbH & Co. KgaA For more information visit http://www.researchandmarkets.com/research/8h3k7s/glaucoma
CANF: 4.47 (+0.07), AGN: 235.41 (-0.27), ACAD: 39.26 (+1.12), ITEK: 6.00 (unch), GILD: 103.42 (+0.36), MRK: 57.98 (+0.10), FOMX: 9.25 (+0.28), AERI: 28.92 (+0.12), CBMG: 32.39 (+2.89)
Investors Are Best To Avoid The IShares Nasdaq Biotechnology ETF
Investing Healthcare - at Seeking Alpha - Mon Mar 02, 9:24AM CST
JNJ: 102.52 (+0.87), BIIB: 425.61 (+11.48), ACAD: 39.26 (+1.12), SPY: 210.46 (+0.23), PCYC: 254.22 (+23.74), GILD: 103.42 (+0.36), MRK: 57.98 (+0.10), ALXN: 185.79 (+3.26), IBB: 347.67 (+7.58), CELG: 120.71 (+1.14)
Steel Is At 5-Year Lows - Cramer's Lightning Round (2/27/15)
SA Editor Mohit Manghnani - at Seeking Alpha - Mon Mar 02, 4:31AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Friday, February 27. Bullish Calls: Acadia Pharmaceuticals (NASDAQ: ACAD ): "We did a piece on Parkinson's and I think they may have something. I like this...
NBL: 46.07 (-1.14), CXO: 113.46 (-0.70), RDS.B: 65.62 (-0.35), ACAD: 39.26 (+1.12), RDS.A: 62.34 (-0.58), TLM: 7.74 (unch), NUE: 47.64 (+0.23), ARUN: 24.41 (+0.01), WOR: 26.51 (-0.16), PGH: 3.16 (-0.10), NXPI: 98.67 (-0.80), ALK: 64.64 (-1.13), ALGT: 189.73 (+4.93)
'Mad Money' Lightning Round: Allegiant Travel Good, Spirit Airlines Better
at The Street - Sat Feb 28, 5:00AM CST
Cramer said Acadia Pharmaceuticals is good but speculative and he's ringing the register on Aruba Networks.
NBL: 46.07 (-1.14), CXO: 113.46 (-0.70), ACAD: 39.26 (+1.12), SAVE: 76.32 (-0.06), TLM: 7.74 (unch), NUE: 47.64 (+0.23), ARUN: 24.41 (+0.01), WOR: 26.51 (-0.16), PGH: 3.16 (-0.10), NXPI: 98.67 (-0.80), ALK: 64.64 (-1.13), ALGT: 189.73 (+4.93)
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Feb 27, 7:31PM CST
What doesn't kill this market makes it stronger, Cramer says. His game plan includes Netflix, Berkshire Hathaway and Costco, among others.
CXO: 113.46 (-0.70), NBL: 46.07 (-1.14), MNST: 140.03 (+0.49), TLM: 7.74 (unch), HON: 103.13 (+0.08), ARUN: 24.41 (+0.01), XOM: 86.74 (-0.44), WOR: 26.51 (-0.16), BBY: 39.63 (-0.16), ATEN: 4.44 (+0.13), ACAD: 39.26 (+1.12), SAVE: 76.32 (-0.06), TGT: 78.20 (+0.48), COST: 151.17 (+4.00), HAWK: 35.14 (-0.42), PGH: 3.16 (-0.10), KR: 74.31 (+4.66), NUE: 47.64 (+0.23), NXPI: 98.67 (-0.80), ALK: 64.64 (-1.13), PLKI: 61.12 (+0.26), ALGT: 189.73 (+4.93), WWAV: 42.42 (-0.06), NFLX: 467.65 (-2.12), PCTY: 28.44 (-0.24), AZO: 650.97 (-1.51), BRK.B: 146.06 (+1.14)
Acadia Pharmaceuticals: Strong Balance Sheet And Several Near-Term Catalysts
Kanak Kanti De - at Seeking Alpha - Fri Feb 27, 3:02PM CST
ACAD: 39.26 (+1.12)
ACADIA Pharmaceuticals' (ACAD) CEO Uli Hacksell on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 26, 8:24PM CST
ACAD: 39.26 (+1.12)
Acadia reports 4Q loss
Automated Insights - Thu Feb 26, 6:22PM CST
SAN DIEGO (AP) _ Acadia Pharmaceuticals Inc. (ACAD) on Thursday reported a loss of $28.4 million in its fourth quarter.
ACAD: 39.26 (+1.12)
ACADIA Pharma misses by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 26, 3:39PM CST
ACAD: 39.26 (+1.12)
Will Epizyme (EPZM) Miss Estimates This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 25, 10:00AM CST
Epizyme, Inc. (EPZM) is expected to report its fourth-quarter 2014 results on Feb 26 and carries a Zacks Rank #3 with an Earnings ESP of 0.00%.
ACAD: 39.26 (+1.12), AMRN: 1.67 (-0.02), EPZM: 24.41 (+0.40)
Is a Surprise Coming for ACADIA Pharmaceuticals (ACAD) This Earnings Season? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 25, 7:54AM CST
ACADIA Pharmaceuticals is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
ACAD: 39.26 (+1.12)
Merrimack Pharmaceuticals (MACK): A Miss this Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 24, 3:10PM CST
Merrimack Pharmaceuticals, Inc. (MACK) is slated to report its fourth-quarter 2014 results on Feb 26 and carries a Zacks Rank #3 with an Earnings ESP of 0.00%.
MACK: 12.48 (+0.70), ACAD: 39.26 (+1.12), BAX: 69.21 (-0.04), AMRN: 1.67 (-0.02)
Will Aegerion (AEGR) Miss Earnings Estimates This Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 24, 2:40PM CST
Aegerion Pharmaceuticals, Inc. (AEGR), slated to report its fourth-quarter 2014 results on Feb 26, carries a Zacks Rank #3 (Hold) with an Earnings ESP of -220.00%.
ACAD: 39.26 (+1.12), AMRN: 1.67 (-0.02), SRPT: 14.08 (+0.02), AEGR: 28.32 (+0.30)
Will Allscripts (MDRX) Surprise Earnings Estimates in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 24, 11:20AM CST
Allscripts Healthcare Solutions Inc (MDRX) is set to report fourth-quarter fiscal 2014 results on Feb 26.
IPXL: 40.08 (-0.32), ACAD: 39.26 (+1.12), MDRX: 12.26 (-0.06), HPTX: 29.80 (+0.07)
Will DexCom (DXCM) Loss Better Estimates this Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 23, 11:10AM CST
We expect DexCom Inc. (DXCM) to post a narrower-than-expected loss figure when it reports fourth quarter and full year 2014 results on Feb 25.
IPXL: 40.08 (-0.32), ACAD: 39.26 (+1.12), DXCM: 60.55 (+0.67), HPTX: 29.80 (+0.07)
Will Wright Medical (WMGI) Disappoint Earnings Again in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 23, 11:00AM CST
Wright Medical Group Inc. (WMGI) is set to report fourth-quarter 2014 results on Feb 25.
IPXL: 40.08 (-0.32), ACAD: 39.26 (+1.12), WMGI: 26.32 (+0.94), HPTX: 29.80 (+0.07)
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q4 2014 Update
John Vincent - at Seeking Alpha - Sat Feb 21, 3:37PM CST
MDLZ: 36.51 (+0.07), DAL: 44.39 (-0.76), KSU: 116.03 (-0.11), AMP: 134.41 (+0.79), LM: 57.25 (+0.25), PCP: 216.34 (+2.82), GOOG: 575.33 (+1.96), HLT: 29.03 (+0.07), DLTR: 79.43 (+0.59), LYB: 87.98 (+0.74), COF: 78.89 (+0.24), FOXA: 34.87 (-0.10), CAR: 60.63 (-0.06), ABBV: 56.86 (-3.41), LOW: 74.56 (+0.54), MA: 92.81 (+1.10), MU: 29.28 (+0.02), ETN: 69.35 (-0.30), FB: 81.21 (+0.32), POT: 34.42 (-1.04), LNG: 78.41 (-0.02), IR: 67.68 (+0.68), NXPI: 98.67 (-0.80), MGM: 21.93 (-0.15), HIG: 40.99 (+0.29), QUNR: 28.99 (+0.39), NFX: 32.77 (-0.41), PXD: 160.44 (-2.57), ABEV: 6.14 (-0.02), ALXN: 185.79 (+3.26), CCI: 86.26 (+0.44), ACT: 295.70 (-0.44), LBTYK: 52.88 (+0.05), C: 53.56 (-0.11), ILMN: 200.13 (+7.45), AON: 100.23 (+0.60), CCE: 44.39 (-0.46), HUM: 162.11 (+1.89), AGN: 235.41 (-0.27), ANTM: 146.85 (+0.30), ACAD: 39.26 (+1.12), LBTYA: 55.00 (+0.14), ALLE: 58.11 (-0.34), GOOGL: 581.43 (+3.10), CTRP: 46.23 (+0.39), BK: 39.19 (-0.25), APD: 154.86 (+0.12), GLNG: 34.35 (+4.84), BRCM: 44.90 (-0.30), BAC: 16.00 (+0.16), NFLX: 467.65 (-2.12), CI: 122.51 (+0.65), HCA: 72.91 (-2.02), BIDU: 214.23 (+6.54), DVA: 76.93 (+0.18), LRCX: 80.77 (-0.10), MHK: 185.18 (+0.15), CP: 193.88 (+3.09), BABA: 86.10 (+0.61)
Can Greatbatch (GB) Keep the Earnings Streak Alive in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 20, 10:20AM CST
We expect Greatbatch Inc. (GB) to beat earnings when the company reports its fourth quarter and full year 2014 financial numbers on Feb 24.
IPXL: 40.08 (-0.32), ACAD: 39.26 (+1.12), GB: 54.73 (+0.34), HPTX: 29.80 (+0.07)
Ecolab's (ECL) Q4 Earnings: Will it Disappoint Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 20, 10:10AM CST
Our proven model does not conclusively show that Ecolab Inc. (ECL) is likely to beat earnings this quarter.
BLUE: 112.23 (+12.18), ENDP: 87.71 (+2.06), ACAD: 39.26 (+1.12), ECL: 116.77 (+0.59)
Next Week In Biotech: Arena And Vivus Report, Radiesse And Avedro Ad Comms
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 20, 8:00AM CST
Every Friday morning, Seeking Alpha posts a calendar of the next week's expected biotech events to start a forward-looking conversation. Please be aware that dates and events can be subject to change. Please let us know in a comment or message if you...
LXRX: 1.12 (+0.07), AMRN: 1.67 (-0.02), HWAY: 22.15 (-0.13), HLS: 42.28 (-0.44), CYBX: 72.03 (+0.84), ESRX: 84.28 (-0.55), ECYT: 6.25 (-0.48), DXCM: 60.55 (+0.67), NSTG: 12.00 (-0.28), SRPT: 14.08 (+0.02), HZNP: 20.84 (-0.33), MDXG: 10.33 (+0.31), DEPO: 24.21 (+0.56), ANIK: 39.96 (+0.50), NKTR: 13.30 (-0.09), KERX: 13.19 (-0.07), ALIM: 4.90 (-0.31), EPZM: 24.41 (+0.40), AEGR: 28.32 (+0.30), MDRX: 12.26 (-0.06), ELGX: 15.96 (-0.08), NUVA: 45.23 (+0.22), HPTX: 29.80 (+0.07), GNMK: 12.82 (+0.24), MDVN: 127.08 (+6.07), HBIO: 5.51 (-0.10), ACAD: 39.26 (+1.12), ST: 56.98 (+0.95), RPTP: 10.77 (+0.47), FMI: 46.97 (-0.32), GMED: 23.76 (-0.27), JAZZ: 174.76 (+2.02), PTCT: 72.72 (+2.26), INFI: 16.51 (+0.34), ARNA: 4.23 (-0.09), EXEL: 3.11 (+0.06), NEO: 4.96 (+0.24), EXAS: 22.43 (+0.53), ALKS: 71.22 (+0.42), HTWR: 85.89 (+1.21), MNKD: 5.73 (-0.21), IPXL: 40.08 (-0.32), SQNM: 3.62 (-0.03), HALO: 15.39 (-0.31), ISIS: 71.76 (+1.60), CLVS: 79.66 (+2.26), BIO: 134.24 (+1.33), BIOS: 5.20 (-0.01), PCRX: 98.40 (+3.01)
(0)
(0)Acadia Pharmaceuticals Inc. (ACAD) Stock Research Links
Scroll down for more posts ▼